Question

Difficulty: HardHematology and Oncology

A 34-year-old woman is admitted to the intensive care unit with a 2-day history of progressively worsening fatigue, fever, and confusion. Her husband notes she has been difficult to arouse this morning. Temperature is 38.2°C (100.8°F), blood pressure is 142/88 mmHg, pulse is 112/min, and respirations are 18/min. Physical examination reveals scleral icterus, pale conjunctivae, and diffuse petechiae over the lower extremities. Neurologic examination shows altered mental status but no focal motor deficits. Laboratory studies show:

Laboratory TestResult
Hemoglobin7.2 g/dL
Platelets18,000/mm³
Leukocytes9,500/mm³
Creatinine1.4 mg/dL
Lactate dehydrogenase1,200 U/L
Total bilirubin3.5 mg/dL
Indirect bilirubin2.8 mg/dL
Prothrombin time12 seconds
Partial thromboplastin time28 seconds

Thrombotic thrombocytopenic purpura (TTP) is strongly suspected. Arrange the following steps in the most appropriate chronological order for the diagnosis and management of this patient.

  1. 1Perform a peripheral blood smear evaluation
  2. 2Collect blood samples for ADAMTS13 activity
  3. 3Commence therapeutic plasma exchange (TPE)
  4. 4Taper plasma exchange frequency after platelet count normalizes

Answer

The correct sequence is: 1) Perform a peripheral blood smear evaluation, 2) Collect blood samples for ADAMTS13 activity, 3) Commence therapeutic plasma exchange (TPE), and 4) Taper plasma exchange frequency after platelet count normalizes.
The management of Thrombotic Thrombocytopenic Purpura (TTP) requires a strict sequence to ensure both accurate diagnosis and life-saving intervention. A peripheral blood smear is the immediate first step to confirm microangiopathic hemolytic anemia (MAHA) through the presence of schistocytes. Once MAHA is suspected in the setting of thrombocytopenia, blood for ADAMTS13 activity must be drawn. Crucially, this draw must occur before any plasma is administered to the patient, as donor plasma contains functional ADAMTS13 and will yield a false-negative assay result. Following the blood draw, therapeutic plasma exchange (TPE) must be initiated immediately; clinicians must not delay TPE while waiting for ADAMTS13 results, which often take days. Finally, TPE is continued daily and then tapered only after clinical response is achieved, indicated by normalization of platelet count and LDH.

Step-by-Step Solution

1
Confirm microangiopathic hemolytic anemia
Peripheral blood smear evaluation
Before initiating invasive treatment, visualization of schistocytes is necessary to differentiate TTP from other causes of thrombocytopenia, such as disseminated intravascular coagulation (DIC), which would typically present with prolonged coagulation times.
2
Obtain baseline enzymatic activity
Collect blood samples for ADAMTS13 activity
The ADAMTS13 assay must be drawn before introducing any donor plasma, which would falsely elevate the patient's measured ADAMTS13 levels and obscure the diagnosis.
3
Initiate lifesaving empirical therapy
Commence therapeutic plasma exchange (TPE)
TPE removes autoantibodies against ADAMTS13 and provides functional enzyme. It must be started immediately without waiting for the ADAMTS13 assay results, as untreated TTP has a mortality rate exceeding 90%.
4
Monitor response and de-escalate
Taper plasma exchange frequency after platelet count normalizes
Once the platelet count and LDH normalize, indicating the cessation of microvascular thrombosis, TPE can be gradually tapered to prevent relapse while minimizing complications.

Key Concept

The chronological diagnosis and management of Thrombotic Thrombocytopenic Purpura (TTP), emphasizing the critical timing of the ADAMTS13 assay relative to the initiation of therapeutic plasma exchange.
Rate this question